CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy, irrespective to atrial fibrillation, after percutaneous coronary intervention in acute coronary syndrome
Ammar, S., Hamouda, M., Abdelhamid, M., Ahmed, S. (2022). CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy, irrespective to atrial fibrillation, after percutaneous coronary intervention in acute coronary syndrome. EKB Journal Management System, 39(3), 954-970. doi: 10.21608/bmfj.2022.155125.1635
Saad Mahmoud Ammar; Mohamed Ahmed Hamouda; Mohamed Wafik Abdelhamid; Shereen Mostafa Ahmed. "CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy, irrespective to atrial fibrillation, after percutaneous coronary intervention in acute coronary syndrome". EKB Journal Management System, 39, 3, 2022, 954-970. doi: 10.21608/bmfj.2022.155125.1635
Ammar, S., Hamouda, M., Abdelhamid, M., Ahmed, S. (2022). 'CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy, irrespective to atrial fibrillation, after percutaneous coronary intervention in acute coronary syndrome', EKB Journal Management System, 39(3), pp. 954-970. doi: 10.21608/bmfj.2022.155125.1635
Ammar, S., Hamouda, M., Abdelhamid, M., Ahmed, S. CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy, irrespective to atrial fibrillation, after percutaneous coronary intervention in acute coronary syndrome. EKB Journal Management System, 2022; 39(3): 954-970. doi: 10.21608/bmfj.2022.155125.1635

CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy, irrespective to atrial fibrillation, after percutaneous coronary intervention in acute coronary syndrome

Benha Medical Journal
Article 18, Volume 39, Issue 3, November and December 2022, Page 954-970  XML PDF (1.1 MB)
Document Type: Original Article
DOI: 10.21608/bmfj.2022.155125.1635
View on SCiNiTO View on SCiNiTO
Authors
Saad Mahmoud Ammar1; Mohamed Ahmed Hamoudaorcid 2; Mohamed Wafik Abdelhamid email 1; Shereen Mostafa Ahmed1
1cardiovascular medicine, Faculty of medicine, Benha University
2Cardiovascular medicine, Faculty of medicine, Benha university
Abstract
Background: Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) are at particularly high risk of contrast-induced nephropathy (CIN), which, when occurring, may be followed by persistent worsening of renal function. The aim of this work was to validate CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy, irrespective to atrial fibrillation, after percutaneous coronary intervention in acute coronary syndrome. Methods: This was a single center, prospective cohort, non-randomized, observational study. This study included 200 patients with acute coronary syndrome who were planned for percutaneous intervention referred to the Department of Cardiology, Universal medical insurance tertiary hospital, Port Said, in the period between September, 2021 to January 2022. These patients were divided into two groups as: Group 1 (with CIN) and Group 2 (without CIN). Results: The current study showed that, CIN cases were significantly associated with higher CHA2DS2-VASc score when compared to those with no CIN. The optimal cut off value was 4, sensitivity was 75%, specificity was 71.4%, PPV was 33.3%, NPV was 93.7%, and accuracy was 72%. For the presence of CHA2DS2-VASc score
Keywords
CHA2DS2-VASc score; Contrast-induced nephropathy; Percutaneous coronary intervention; Acute coronary syndrome
Statistics
Article View: 119
PDF Download: 271